rosiglitazone has been researched along with Acute Kidney Injury in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, R; Cao, Q; Cui, X; Gao, X; Lin, Y; Liu, S; Quan, F; Su, Y; Wang, Y; Yang, Y; Yue, C; Zhang, D; Zhang, M; Zhao, Q | 1 |
| Chen, E; Huang, J; Wu, J; Zheng, X | 1 |
| Chen, Y; Dai, Y; Gao, H; Huang, Y; Jin, R; Mo, D; Yan, Q; Zhang, C; Zhang, L | 1 |
| Dias, C; Helou, CM; Volpini, RA | 1 |
| Deng, J; Yu, J | 2 |
| Ji, K; Wang, H; Wang, R; Wu, X; Yan, Z; Zang, B | 1 |
| Abdul Ghani, R; Kamaruddin, NA; Kong, NC; Zainudin, S | 1 |
| Cho, WY; Jo, SK; Kim, HK; Kim, HW; Kim, MG; Yang, HN | 1 |
1 trial(s) available for rosiglitazone and Acute Kidney Injury
| Article | Year |
|---|---|
Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR
Topics: Acute Kidney Injury; Animals; Caspase 3; Creatinine; Furosemide; Interleukin-10; Iohexol; Kidney; Nitrogen; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Urea | 2022 |
8 other study(ies) available for rosiglitazone and Acute Kidney Injury
| Article | Year |
|---|---|
ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
Topics: Acute Kidney Injury; Animals; Coenzyme A Ligases; Female; Ferroptosis; Humans; Male; Mice; Rosiglitazone | 2022 |
Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
Topics: Acute Kidney Injury; Animals; Cell Death; Epithelial Cells; Fibrosis; Humans; Mice; Neurodegenerative Diseases; Rosiglitazone | 2023 |
Rosiglitazone did not induce acute kidney injury in normocholesterolemic rats despite reduction in glomerular filtration rate.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Cholesterol; Glomerular Filtration Rate; Hypercholesterolemia; Hypoglycemic Agents; Lipid Metabolism; Lipocalin-2; Lipocalins; Magnesium; Male; Proto-Oncogene Proteins; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Thiobarbituric Acid Reactive Substances | 2013 |
[Effects of rosiglitazone on levels of TNFα in septic rats with acute kidney injury].
Topics: Acute Kidney Injury; Animals; Cecum; Disease Models, Animal; Inflammation; Kidney; Ligation; Male; Punctures; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis.
Topics: Acute Kidney Injury; Animals; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hyperlipidemias; Hypoglycemic Agents; Immunohistochemistry; In Situ Nick-End Labeling; Male; Pancreatitis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2015 |
[Rosiglitazone protects acute kidney injury in septic rats].
Topics: Acute Kidney Injury; Animals; Apoptosis; Blotting, Western; Cecum; Kidney; Ligation; Male; Peroxidase; PPAR gamma; Punctures; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones | 2016 |
Acute renal failure following the use of rosiglitazone in a chronic kidney disease patient.
Topics: Acute Kidney Injury; Aged; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mycophenolic Acid; Renal Dialysis; Rosiglitazone; Thiazolidinediones | 2009 |
IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Apoptosis; Caspases; Chemokines; Cisplatin; Cytokines; Enzyme Activation; Hypoglycemic Agents; Interleukin-10; Kidney; Male; Mice; Mice, Inbred BALB C; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |